Chromatography
Non-invasive Cancer Detection System Uses Sensing Ocean Optics Expertise
Dec 20 2005
Developed by the Bioscience Division of the U.S. Department of Energy, the technology has been licensed to, and further developed by, SpectraPath Technologies. It is hoped that the system will allow physicians to screen patients quickly, providing instant diagnoses, without requiring invasive and time-consuming biopsies for skin, cervical, brain, oesophageal and colorectal cancers.
At the heart of the system is a USB2000 palm sized spectrometer. It is used to analyse the elastic light scattering (ELS) spectrum produced by cellular nuclei. An LS-1 Tungsten Halogen Light Source and single optical fibre probe are used to illuminate the tissue surface. The probe then captures the resulting ELS spectrum. Larger nuclei in cancerous and pre-cancerous cells cause different ELS spectra from normal nuclei.
The CancerScanner? has so far been successfully tested in both animals and humans for a variety of cancer types. It is small, lightweight, and will be economically practical for hospitals, physician offices and patient services centres.
Digital Edition
ILM 49.5 July
July 2024
Chromatography Articles - Understanding PFAS: Analysis and Implications Mass Spectrometry & Spectroscopy Articles - MS detection of Alzheimer’s blood-based biomarkers LIMS - Essent...
View all digital editions
Events
Jul 28 2024 San Diego, CA USA
Jul 30 2024 Jakarta, Indonesia
Jul 31 2024 Chengdu, China
ACS National Meeting - Fall 2024
Aug 18 2024 Denver, CO, USA
Aug 25 2024 Copenhagen, Denmark